Status:
COMPLETED
Role of Stress CMR in Predicting Adverse Clinical Events in Patients With Known or Suspected IHD
Lead Sponsor:
Brigham and Women's Hospital
Conditions:
Coronary Artery Disease
Eligibility:
All Genders
21-100 years
Brief Summary
The investigators plan to use retrospective data to assess heart function and structure abnormalities through the use of an approved vasodilating agent for stress cardiac MRI tests. The investigators ...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Age \>/= 21 years old
- No contraindications for cardiac MRI (by renal function or metallic hazards)
Exclusion
Key Trial Info
Start Date :
January 30 2012
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 30 2018
Estimated Enrollment :
2347 Patients enrolled
Trial Details
Trial ID
NCT01821924
Start Date
January 30 2012
End Date
August 30 2018
Last Update
November 6 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Brigham and Women's Hospital
Boston, Massachusetts, United States, 02115
2
Massachusetts General Hospital
Boston, Massachusetts, United States, 02215